Daniela A. Gutierrez
Santiago, RM 8331150, Chile
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
The c-Abl-RIPK3 Axis Drives Mitochondrial Dysfunction and Impaired Mitophagy in Gaucher Disease Models.
Journal: Antioxidants (Basel, Switzerland)
Published: March 05, 2026
c-Abl tyrosine kinase down-regulation as target for memory improvement in Alzheimer's disease.
Journal: Frontiers in aging neuroscience
Published: March 06, 2023
Amyloid β-Peptide Causes the Permanent Activation of CaMKIIα through Its Oxidation.
Journal: International journal of molecular sciences
Published: October 13, 2022
Prophylactic treatment with the c-Abl inhibitor, neurotinib, diminishes neuronal damage and the convulsive state in pilocarpine-induced mice.
Journal: Cell reports
Published: August 02, 2022
c-Abl kinase at the crossroads of healthy synaptic remodeling and synaptic dysfunction in neurodegenerative diseases.
Journal: Neural regeneration research
Published: July 28, 2022
Amyloid Beta-Peptide Increases BACE1 Translation through the Phosphorylation of the Eukaryotic Initiation Factor-2α.
Journal: Oxidative medicine and cellular longevity
Published: June 19, 2020
c-Abl regulates a synaptic plasticity-related transcriptional program involved in memory and learning.
Journal: Progress in neurobiology
Published: June 15, 2020
Genotoxic stress triggers the activation of IRE1α-dependent RNA decay to modulate the DNA damage response.
Journal: Nature communications
Published: April 18, 2019
c-Abl Deficiency Provides Synaptic Resiliency Against Aβ-Oligomers.
Journal: Frontiers in cellular neuroscience
Published: April 08, 2019
Human Albumin Impairs Amyloid β-peptide Fibrillation Through its C-terminus: From docking Modeling to Protection Against Neurotoxicity in Alzheimer's disease.
Journal: Computational and structural biotechnology journal
Published: January 18, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026